Anika Therapeutics (ANIK) Current Deferred Revenue (2010 - 2026)
Anika Therapeutics' (ANIK) quarterly Current Deferred Revenue came in at $122000.0 in Q2 2026, down 46.72% quarter-over-quarter from $229000.0 in Q1 2026.
Powered by 
Analysis
Anika Therapeutics (ANIK) Current Deferred Revenue (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Current Deferred Revenue for 8 consecutive years, with $122000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $122000.0 in Q2 2026; TTM through Jun 2026 was $122000.0, a N/A change from a year earlier, with the FY2014 full-year figure at $24510.0, down 98.9% from the prior year.
- Current Deferred Revenue was $122000.0 for Q2 2026 at Anika Therapeutics, down from $229000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $229000.0 in Q1 2026 and troughed at $122000.0 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Anika Therapeutics | 277.93 Mn | 239.52 Mn | 21.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122,000.00 |
| Mar 31, 2026 | 229,000.00 |
| Sep 30, 2018 | 52,000.00 |
| Jun 30, 2018 | 74,000.00 |
| Sep 30, 2015 | 33,948.00 |
| Jun 30, 2015 | 35,938.00 |
| Mar 31, 2015 | 139,535.00 |
| Dec 31, 2014 | 24,510.00 |
| Sep 30, 2014 | 12,885.00 |
| Jun 30, 2014 | 15,463.00 |
| Mar 31, 2014 | 46,412.00 |
| Dec 31, 2013 | 2.24 Mn |
| Sep 30, 2013 | 850,067.00 |
| Jun 30, 2013 | 1.53 Mn |
| Mar 31, 2013 | 2.19 Mn |
| Dec 31, 2012 | 5.03 Mn |
| Sep 30, 2012 | 2.87 Mn |
| Jun 30, 2012 | 2.87 Mn |
| Mar 31, 2012 | 2.87 Mn |
| Dec 31, 2011 | 7.89 Mn |